Target intelligence / Profile preview

Novel transcript, antisense to TMEM55A

Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

ENSG00000308751, described as a "novel transcript, antisense to TMEM55A," is annotated in Ensembl as a long non-coding RNA (lncRNA). This transcript is generated from the opposite strand of the TMEM55A (PIP4P2) locus, but there is no current evidence that it codes for a protein or serves as a direct therapeutic/functional target. It may play a regulatory role at the RNA level, but no specific biological functions, disease involvement, or drugs are associated with it at this time[5].

Other names
ENSG00000308751Antisense lncRNA to TMEM55A

Beyond the preview

Go deeper on Novel transcript, antisense to TMEM55A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TMEM55A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call